natgillin/translations-raw huggingface dataset:
Cmax was comparable between juveniles and adults starting at month 1, indicating no increased risk of acute toxicity. 
Pri mladih psih je bila vrednost Cmax primerljiva z odraslimi od 1. meseca dalje, kar kaže na to, da ni povečanega tveganja za akutno toksičnost.
The product can be administered as part of a seasonal prevention strategy when fleas and mosquitoes or snails/slugs are present. 
To zdravilo se lahko daje kot del sezonske strategije preventive, kadar so prisotne bolhe in komarji ali polži.
Speke Operations Fleming Road Liverpool 
Speke Operations Fleming Road
The safety of this product in avermectin sensitive dogs/dogs with an MDR-1 mutation has not been sufficiently demonstrated. 
Varnost tega zdravila pri psih, občutljivih za avermektin, in psih z mutacijo MDR-1 ni zadostno dokazana.
The blister packs are formed from aluminium laminates, heat sealed with a PVC based coating (the product contact surface is PVC). 
Pretisni omoti so izdelani iz aluminijevih laminatov in toplotno zapečateni s prevleko na osnovi PVC-ja (stična površina je iz PVCja).
Chewable tablets. 
Žvečljive tablete.
Milbemycin oxime plasma concentrations and some pharmacokinetic parameters are increased in the presence of spinosad. 
Plazemske koncentracije milbemicin oksima in nekateri farmakokinetični parametri se v prisotnosti spinosada povečajo.
The use of the product should be based on the confirmed diagnosis of mixed infection (or risk of infection, where prevention applies) at the same time (see also section 4.2). 
Uporaba zdravila mora temeljiti na potrjeni diagnozi mešane okužbe (ali na tveganju za okužbo, kjer je potrebna preventiva) (glejte tudi poglavje 4.2).
Spinosad is excreted in the colostrum and milk of lactating bitches. 
Spinosad se izloča v kolostrum in mleko psic v laktaciji.
After administration of the tablet monitor the dog closely. 
Po dajanju tablete psa pozorno opazujte.
Plasma protein binding is high (>98%). 
Vezava na beljakovine v plazmi je visoka (> 98 %).
Strength and number of tablets to be administered: 
Jakost in število tablet, ki jih je treba dati:
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents - endectocides. 
Farmakoterapevtska skupina: zdravila proti zajedavcem, insekticidi in repelenti - endektocidi.
Cats in the household should be treated with a product authorised for use in that species. 
Mačke v gospodinjstvu zdravimo z zdravilom, ki je odobreno za uporabo pri tej živalski vrsti.
At acute overdoses corresponding to 3 times the maximum recommended dose, vomiting occurred in half of the animals, sometimes repeatedly. 
Pri akutnih prevelikih odmerkih, ki ustrezajo 3-kratnemu največjemu priporočenemu odmerku, je do bruhanja prišlo pri polovici živali, včasih tudi večkrat.
These dogs may be at a higher risk for adverse effects when treated with this product and should therefore be treated with special caution. 
Ti psi so lahko med zdravljenjem s tem zdravilom bolj izpostavljeni tveganju za pojav neželenih učinkov, zato jih je treba obravnavati posebej previdno.
This leads to hyperpolarisation of the neuromuscular membrane and flaccid paralysis and death of the parasite. 
To vodi v hiperpolarizacijo živčno-mišične membrane ter ohlapno paralizo in pogin zajedavca.
Do not use this veterinary medicinal product after the expiry date which is stated on the blister after EXP. 
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na pretisnem omotu za oznako »EXP«.
The mean Tmax for milbemycin A3 and A4 5-oximes was typically 4 hours and the mean elimination half-lives were 33.9 and 77.2 hours. 
Srednji čas Tmax za milbemicin A3 in A4 5-oksima je bil običajno 4 ure, srednja razpolovna časa izločanja pa 33,9 in 77,2 ure.
Excretion is primarily via faeces, and also to a lesser extent in the urine. 
Zdravilo se izloča predvsem z blatom in v manjši meri z urinom.
Plasma protein binding is high (>96%). 
Vezava na beljakovine v plazmi je visoka (> 96 %).
The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). 
To zdravilo lahko uporabljamo kot del strategije zdravljenja za nadzor alergijskega dermatitisa, ki ga povzročajo bolhe (Flea Allergy Dermatitis - FAD).
In case of adverse clinical signs, treat symptomatically. 
V primeru neželenih kliničnih znakov zdravite simptomatsko.
Do not use in case of hypersensitivity to the active substances or to any of the excipients. 
Ne uporabite v primeru preobčutljivosti na zdravilni učinkovini ali na katero koli pomožno snov.
At three times the maximum recommended dose adverse events of potentially neurological origin e.g. decreased activity (8%), hypersalivation (17%) or stumbling (8%) were observed. 
Pri trikratnem največjem priporočenem odmerku so opazili neželene učinke, ki so morda nevrološkega izvora, npr. zmanjšana aktivnost (8 %), slinjenje (17 %) ali spotikanje (8 %).
In case of adverse reactions consult your veterinarian. 
V primeru neželenih učinkov se posvetujte z veterinarjem.
If vomiting occurs within an hour of administration and the tablet is visible, re-dose with another full dose. 
Če se v eni uri po odmerku pojavi bruhanje, v katerem opazite tableto, dajte psu še enkrat polni odmerek.
In case of a massive flea infestation, and at the beginning of the control measures, these areas should be treated with a suitable insecticide and then vacuumed regularly. 
Te je treba v primeru hude infestacije in ob začetku nadzornih ukrepov obdelati z ustreznim insekticidom ter jih nato redno sesati.
When Trifexis is used to replace another heartworm preventive product, the first dose of Trifexis must be given within a month of the last dose of the former medication. 
Kadar se zdravilo Trifexis uporablja kot zamenjava drugega zdravila za preprečevanje okužb s srčno glisto, je treba dati prvi odmerek zdravila Trifexis v enem mesecu od zadnjega odmerka prejšnjega zdravila.
At acute overdoses corresponding to 1.5 times the maximum recommended dose, vomiting occurred in 17% of the dogs, and hypersalivation occurred in 8% of the dogs. 
Pri akutnih prevelikih odmerkih, ki ustrezajo 1,5-kratnemu največjemu priporočenemu odmerku, se je bruhanje pojavilo pri 17 % psov in slinjenje pri 8 % psov.
A slight increase in plasma liver enzymes and haemoglobin distribution width (HDW) was observed during the study but no clinically relevant signs was attributed to these changes. 
V času študije so opazili rahlo povišanje jetrnih encimov v plazmi in širine distribucije hemoglobina (haemoglobin distribution width - HDW), vendar tem spremembam niso pripisovali klinično pomembnih znakov.
Special precautions for use in animals: Use with caution in dogs with pre-existing epilepsy. 
Posebni previdnostni ukrepi za uporabo pri živalih: Previdnost je potrebna pri psih z epilepsijo.
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/). 
DATUM ZADNJE ODOBRITVE NAVODIL ZA UPORABO Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) http://www.ema.europa.eu/.
Dogs 
psi
Milbemycin oxime is an antiparasitic endectocide belonging to the macrocyclic lactones. 
Milbemicin oksim je antiparazitni endektocid, ki spada v skupino makrocikličnih laktonov.
Trifexis tablets should only be used when the veterinarian has confirmed diagnosis of mixed infection (or risk of infection, where prevention applies) at the same time (see section 4). 
Tablete Trifexis se smejo uporabiti samo, če je veterinar potrdil diagnozo sočasne mešane okužbe (ali tveganje za okužbo, kadar se zdravilo uporablja kot preventiva) (glejte poglavje 4).
PACKAGE SIZE 1 chewable tablet 3 chewable tablets 6 chewable tablets 
VELIKOST PAKIRANJA 1 žvečljiva tableta 3 žvečljive tablete 6 žvečljivih tablet
Further information for the prescribing veterinarian: 
Nadaljnje informacije za veterinarja, ki zdravilo predpiše:
It does not interact with known binding sites of other nicotinic or GABAergic insecticides such as neonicotinides (imidacloprid or nitenpyram), fiproles (fipronil), milbemycins, avermectins (e.g. selamectin) or cyclodienes but through a novel insecticidal mechanism. 
Nima medsebojnega delovanja z znanimi mesti vezave drugih nikotinskih ali GABAergičnih insekticidov, kot so neonikotinidi (imidakloprid ali nitenpiram), fiproli (fipronil), milbemicini, avermektini (npr. selamektin) ali ciklodieni, ampak s povsem novim insekticidnim mehanizmom.
There is no antidote available. 
Protistrupa ni.
Accidental ingestion may cause adverse reactions. 
Nenamerno zaužitje lahko povzroči neželene učinke.
After treatment of the nematode infection, further flea prevention should be continued with a monovalent product. 
Po zdravljenju okužbe z želodčno-črevesnimi nematodi se lahko preprečevanje infestacije z bolhami nadaljuje z monovalentnim izdelkom.
Spinosad comprises spinosyn A and spinosyn D. The insecticidal activity of spinosad is characterised by nervous excitation leading to muscle contractions and tremors, prostration, paralysis and rapid death of the flea. 
Spinosad je sestavljen iz spinosina A in spinosina D. Za insekticidno aktivnost spinosada je značilna živčna razdraženost, ki povzroči krčenje mišic in tremorje, izčrpanost, paralizo in hitro smrt bolh.
The activity of milbemycin oxime is related to its action on invertebrate neurotransmission. 
Delovanje milbemicin oksima je povezano z njegovim delovanjem na živčni prenos pri nevretenčarjih.
THE WORDS “FOR ANIMAL TREATMENT ONLY” For animal treatment only. 
BESEDILO »SAMO ZA ŽIVALI« Samo za živali.
Postmarketing reports for spinosad indicate that in very rare cases, blindness, impaired vision and other eye disorders were observed. 
Iz izkušenj uporabe spinosada izhaja, da so v zelo redkih primerih opazili slepoto, slabovidnost in druge očesne bolezni.
A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE 
A. IZDELOVALEC, ODGOVOREN ZA SPROSTITEV SERIJE
Adverse reactions seen during the course of this study included vomiting, diarrhoea, skin lesions, salivation, tremors, decreased activity, coughing and vocalization. 
Med neželenimi učinki, opaženimi med to študijo, so bili bruhanje, diareja, kožne lezije, slinjenje, tremor, zmanjšana aktivnost, kašelj in vokalizacija.
Milbemycin oxime, like avermectins and other milbemycins, increases nematode and insect membrane permeability to chloride ions via glutamate-gated chloride ion channels (related to vertebrate GABA and glycine receptors). 
Milbemicin oksim, kakor avermektini in drugi milbemicini, povečuje prepustnost membran nematodov in insektov za kloridne ione prek od glutamata odvisnih kloridnih ionskih kanalov (sorodnih receptorjem GABA in glicinskim receptorjem pri vretenčarjih).
Trifexis can be used as part of the seasonal prevention of fleas (replacing treatment with a monovalent flea product) in dogs with diagnosed concurrent gastrointestinal nematode infections. 
Zdravilo Trifexis se lahko uporablja kot del sezonske preventive proti bolham (namesto zdravljenja z monovalentnim izdelkom proti bolham) pri psih z diagnozo sočasne okužbe prebavil z želodčnočrevesnimi nematodi.
Based on the local epidemiological situation, the veterinary medicinal product may be given at monthly intervals throughout the season at the recommended dose as outlined below. 
Glede na lokalne epidemiološke okoliščine se lahko to zdravilo v priporočenih odmerkih daje v mesečnih intervalih skozi vso sezono, kakor je opisano spodaj.
It is active against mites, larval and adult stages of nematodes as well as larvae of Dirofilaria immitis. 
Deluje proti pršicam, odraslim nematodom in njihovim ličinkam, kot tudi proti ličinkam filarije Dirofilaria immitis.
Mottled tan to brown, round, biconvex tablets with a debossed code on one side and dimples on the other side. 
Lisaste rumenorjave do rjave, okrogle, bikonveksne tablete z vtisnjeno oznako na eni strani in vdolbinicami na drugi strani.
In studies performed with spinosad only, the primary biliary, faecal and urinary metabolites in both rat and dog were identified as the demethylated spinosyns, glutathione conjugates of the parent compounds and N-demethylated spinosyns A and D. Excretion is primarily via the bile and faeces, and to a lesser extent in the urine. 
V študijah, opravljenih s samim spinosadom, so glavne presnovke v žolču, blatu in urinu pri podganah in psih opredelili kot demetilirane spinosine, glutationske konjugate starševskih spojin in Ndemetilirana spinosina A in D. Glavna pot izločanja je z žolčem in blatom, v manjši meri pa z urinom.
After oral administration of 45 mg spinosad and 0.75 mg milbemycin oxime/kg bodyweight to fed dogs, spinosyns A and D are rapidly absorbed and extensively distributed. 
Po peroralni uporabi 45 mg spinosada in 0,75 mg milbemicin oksima/kg telesne mase pri nahranjenih psih se spinosina A in D hitro absorbirata in obsežno porazdelita.
At doses of 30 to 60 mg spinosad and 0.5 to 1 mg milbemycin oxime per kg bodyweight, lethargy, anorexia/decreased appetite, diarrhoea, pruritus, dermatitis and reddening of the skin and pinna were commonly seen. 
Pri odmerkih od 30 do 60 mg spinosada in 0,5 do 1 mg milbemicin oksima na kg telesne mase so se pogosto pojavili tudi letargija, anoreksija/zmanjšanje apetita, diareja, pruritus, dermatitis ter pordelost kože in uhljev.
For the prevention of lungworm disease by reducing the level of infection with immature adult (L5) Angiostrongylus vasorum larvae and the concurrent treatment and prevention of flea infestation, the veterinary medicinal product must be given at regular monthly intervals during the time of the year when snails/slugs and fleas are present. 
Za preprečevanje angiostrongiloze z zmanjšanjem stopnje okužbe z nezrelo odraslo obliko (L5) Angiostrongylus vasorum larve ter sočasno zdravljenje in preprečevanje infestacij z bolhami je treba to zdravilo dajati v rednih mesečnih intervalih v tistem obdobju leta, ko so prisotni polži in bolhe.
Spinosad and milbemycin oxime have been shown to be substrates for P-glycoprotein (P-gp) and therefore could interact with other P-gp substrates (for example, digoxin, doxorubicin) or other macrocyclic lactones. 
Dokazano je, da sta spinosad in milbemicin oksim substrata za P-glikoprotein (P-gp), zato lahko medsebojno delujeta z drugimi P-gp substrati (npr. digoksinom in doksorubicinom) ali drugimi makrocikličnimi laktoni.
PHARMACEUTICAL FORM Chewable tablets 
FARMACEVTSKA OBLIKA Žvečljive tablete.
The primary faecal and urinary metabolites in dog were identified as glucuronide conjugates of milbemycin A3 or A4 5-oximes, dealkylated milbemycin A3 or A4 5-oximes, and hydroxylated milbemycin A4 5-oxime. 
Glavne presnovke v blatu in urinu pri psih so opredelili kot glukuronidne konjugate milbemicina A3 ali A4 5-oksima, dealkiliranega milbemicin A3 ali A4 5-oksima in hidroksiliranega milbemicin A4 5oksima.
Milbemycin oxime is isolated from the fermentation of Streptomyces hygroscopicus var. aureolacrimosus. 
Izoliran je iz fermentacije z bakterijsko vrsto Streptomyces hygroscopicus var. aureolacrimosus.
It is recommended to observe the treated dog up to 24 hours post-administration of the product for possible adverse reactions (see section 6). 
Priporočamo vam, da zdravljenega psa opazujete do 24 ur po uporabi zdravila zaradi možnih neželenih učinkov (glejte poglavje 6).
Bodyweight (kg) of dog 
Telesna masa psa (kg)
At doses in excess of the recommended dose, vomiting becomes a very common event. 
Pri odmerkih, ki presegajo priporočenega, se bruhanje pojavlja zelo pogosto.
Milbemycin A4 5-oxime tends to eliminate slower resulting in approximately 10-fold higher exposure than Milbemycin A3 5-oxime. 
Milbemicin A4 5-oksim se izloča počasneje, zato je izpostavljenost približno 10-krat večja v primerjavi z milbemicin A3 5-oksimom.
Use with caution in dogs with pre-existing epilepsy. 
Previdnost je potrebna pri psih z epilepsijo.
The following list shows the code and the number of dimples marked on each strength of tablet: Trifexis 270 mg/4.5 mg tablets: 
Na naslednjem seznamu so oznake in število vdolbinic na tabletah različnih jakosti: Trifexis 270 mg/4,5 mg tablete:
The veterinary medicinal product should be administered in accordance with the following table to ensure a dose of 45 to 70 mg spinosad and 0.75 to 1.18 mg milbemycin oxime/kg bodyweight. 
Zdravilo se daje skladno z naslednjo tabelo, da se zagotovita odmerek spinosada 45-70 mg/kg telesne mase in odmerek milbemicin oksima 0,75-1,18 mg/kg telesne mase.
Manufacturer responsible for batch release: Eli Lilly and Company Ltd Speke Operations 
Izdelovalec, odgovoren za sproščanje serij: Eli Lilly and Company Ltd Speke Operations
Based on the local epidemiological situation and the decision of the prescribing veterinarian, the veterinary medicinal product may be given at monthly intervals throughout the season at the recommended dose as outlined below. 
Glede na lokalne epidemiološke okoliščine in po presoji odgovornega veterinarja se lahko to zdravilo v priporočenih odmerkih daje v mesečnih intervalih skozi vso sezono, kakor je opisano spodaj.
Prior to first use of this product, dogs in heartworm endemic areas or who have visited heartworm endemic areas must be tested for existing heartworm infection. 
Pred prvo uporabo tega zdravila je treba pse, ki živijo na endemičnih območjih za srčno glisto ali ki so tako območje obiskali, testirati na obstoječo okužbo z glisto.
The excretion of milbemycin oxime in lactating dogs (bitches) has not been tested and the safety for suckling puppies has not been established. 
Izločanje milbemicin oksima pri psicah v laktaciji ni preverjeno in varnost za mladiče, ki sesajo materino mleko, ni ugotovljena.
Dogs living in non-heartworm endemic areas: 
Psi, ki živijo na območjih, ki niso endemična za srčno glisto:
In dogs, hydroxymilbemycin A4 5-oxime was detected only in plasma, but not in urine or faeces, suggesting predominant excretion of conjugated metabolites in the dog. 
Pri psih so odkrili hidroksimilbemicin A4 5-oksim samo v plazmi, ne pa tudi v urinu in blatu, kar kaže, da se pri psih izločajo predvsem konjugirani presnovki.
Dogs travelling to a heartworm region should start medication within a month after arrival there. 
Pse, ki bodo obiskali endemično območje za srčno glisto, je treba začeti zdraviti najpozneje en mesec po prihodu na to območje.
After spinosad administration, the incidence of vomiting on the day of, or the day after dosing has been observed to increase as a function of the dose. 
Opazili so, da se je po dajanju spinosada pojavnost bruhanja na dan odmerjanja ali naslednji dan povečala sorazmerno z odmerkom.
No studies have been performed in sick or convalescent dogs, therefore the product should only be used based on a benefit-risk assessment of the responsible veterinarian. 
Pri bolnih in psih v okrevanju niso izvedli nobenih študij, zato se sme zdravilo uporabljati samo na podlagi ocene koristi in tveganj, ki jo opravi odgovorni veterinar.
Approximately 90% of spinosad is comprised of spinosyns A and D. Of that 90%, the ratio of spinosyn A to A+D is 0.85 when calculated as spinosyn A/spinosyn A+D. 
Približno 90 % spinosada sestavljata spinosina A in D. Od teh 90 % je razmerje med spinosinom A in A + D 0,85, če se izračuna kot spinosin A/spinosin A + D. Konsistentnost te številke v farmakokinetičnih in drugih študijah kaže na primerljivost absorpcije, presnove in izločanja dveh glavnih spinosinov.
Special precautions for each target species: 
Posebna opozorila za vsako živalsko vrsto:
The safe use of the maximum recommended dose (70 mg/kg spinosad and 1.18 mg/kg milbemycin oxime) given as capsules has been demonstrated for 12 months. 
Varno uporabo največjega priporočenega odmerka (70 mg/kg spinosada in 1,18 mg/kg milbemicin oksima), danega v obliki kapsul, so dokazali za obdobje 12 mesecev.
Regular monthly treatments with the insecticidal active substance in this product (spinosad) break the fleas' life cycle and may be used to control the flea population in contaminated households. 
Redna mesečna uporaba insekticidne učinkovine v tem zdravilu (spinosada) prekine življenjski cikel bolhe in se lahko uporablja za nadzor populacije bolh v okuženih gospodinjstvih.
Fleas from pets often infest the animal's basket, bedding and regular resting areas such as carpets and soft furnishings. 
Bolhe domačih živali pogosto infestirajo košaro živali, ležišče in prostore, v katerih žival redno počiva, kot so preproge in oblazinjeno pohištvo.
Treatment and prevention of flea infestation when concurrent prevention of heartworm disease, angiostrongylosis and/or concurrent treatment of nematode infections is indicated. 
Zdravljenje in preprečevanje infestacij z bolhami, kadar je indicirano sočasno preprečevanje dirofilarioze, angiostrongiloze in/ali sočasno zdravljenje okužb z nematodi.
Milbemycin A3 and A4 5-oximes are rapidly absorbed and extensively distributed in dogs after oral administration. 
Milbemicin A3 in A4 5-oksimi se pri psih po peroralni uporabi hitro absorbirajo in obsežno porazdelijo.
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY OR USE 
POGOJI DOVOLJENJA ZA PROMET Z ZDRAVILOM TER OMEJITVE GLEDE OSKRBE IN UPORABE
Prior to first administration, dogs in heartworm endemic areas or who have visited heartworm endemic areas must be tested for existing heartworm infection. 
Pred prvim dajanjem je treba pse, ki živijo na endemičnih območjih za srčno glisto ali ki so tako območje obiskali, testirati na obstoječo okužbo z glisto.
NAME OF THE MARKETING AUTHORISATION HOLDER Eli Lilly and Company Ltd 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Eli Lilly and Company Ltd
Microcrystalline cellulose Hydroxypropyl cellulose Silica, colloidal anhydrous Croscarmellose sodium Magnesium stearate Artificial beef flavour 
6.1 Seznam pomožnih snovi mikrokristalna celuloza hidroksipropilceluloza brezvodni koloidni silicijev dioksid natrijeva kroskarmeloza magnezijev stearat umetna aroma govedine
Safe use in overdose situations up to 3.6 times the recommended dose has been demonstrated following 6 monthly administrations. 
Varnost zdravila pri prevelikem odmerjanju z do 3,6-kratnim največjim priporočenim odmerkom zdravila so dokazali po 6 mesečnih odmerjanjih.
Marketing authorisation holder: Eli Lilly and Company Ltd Elanco Animal Health Priestley Road 
Imetnik dovoljenja za promet z zdravilom: Eli Lilly and Company Ltd Elanco Animal Health Priestley Road
The following list shows the code and the number of dimples marked on each strength of tablet: 
Na naslednjem seznamu so oznake in število vdolbinic na tabletah različnih jakosti:
For the prevention of heartworm disease and the concurrent treatment and prevention of flea infestations, the veterinary medicinal product must be given at regular monthly intervals during the time of the year when mosquitoes and fleas are present. 
Za preprečevanje dirofilarioze ter sočasno zdravljenje in preprečevanje infestacij z bolhami je treba to zdravilo dajati v rednih mesečnih intervalih v tistem obdobju leta, ko so prisotni komarji in bolhe.
Regular monthly treatments with the insecticidal active substance, spinosad, break the fleas' life cycle and may be used to control the flea population in contaminated households. 
Redna mesečna uporaba insekticidne učinkovine spinosad prekine življenjski cikel bolhe in se lahko uporablja za nadzor populacije bolh v okuženih gospodinjstvih.
Laboratory studies on the effect of spinosad and milbemycin oxime in rats and rabbits have neither produced any evidence of teratogenic, foetotoxic or maternotoxic effects, nor any effect on the reproductive capacity in males and females. 
Laboratorijske študije učinkov spinosada in milbemicin oksima na podganah in kuncih niso dokazale teratogenih in fetotoksičnih učinkov, toksičnih učinkov na mater ali učinkov na sposobnost razmnoževanja samcev in samic.
Carton containing 1 blister pack. 
Škatla vsebuje en pretisni omot.
Dogs living in heartworm endemic areas: 
Psi, ki živijo na endemičnih območjih za srčno glisto: